Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.200
-0.050 (-4.00%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Revenue
Metagenomi Therapeutics had revenue of $1.25M in the quarter ending March 31, 2026, a decrease of -69.76%. This brings the company's revenue in the last twelve months to $22.33M, down -50.66% year-over-year. In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%.
Revenue (ttm)
$22.33M
Revenue Growth
-50.66%
P/S Ratio
2.02
Revenue / Employee
$187,655
Employees
119
Market Cap
45.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.21M | -27.09M | -51.79% |
| Dec 31, 2024 | 52.30M | 7.54M | 16.84% |
| Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
| Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
| Dec 31, 2021 | 243.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 5 days ago - Metagenomi Therapeutics Transcript: AGM 2026 - Transcripts
- 9 days ago - Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 10 days ago - Metagenomi Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Metagenomi price target lowered to $9 from $12 at Wells Fargo - TheFly
- 4 weeks ago - Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - Metagenomi Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Metagenomi Therapeutics Quarterly report: Q1 2026 - Filings